Venous Thromboembolism Following Abdominal Cancer Surgery in the Korean Population: Incidence and Validation of a Risk Assessment Model

  • Mi-hyeong Kim
  • Kang-woong Jun
  • Jeong-kye Hwang
  • Sang-dong Kim
  • Jang-yong Kim
  • Sun-cheol Park
  • Yong-sung Won
  • Sang-seop Yun
  • In-sung Moon
  • Ji-il KimEmail author
Gastrointestinal Oncology



A cancer patient slated for abdominal surgery is considered to be at moderate to high risk for developing venous thromboembolism (VTE), but the incidence is quite low in Korean patients. Most risk assessment models and recommendations for VTE management are from Western reports, however they possibly overestimate the risk of VTE in the Korean population.


We retrospectively reviewed the medical records of 1966 patients who were diagnosed with abdominal organ cancer and required surgical treatment.


Each patient was rated using the Caprini risk scoring model. The mean score was 7.5 ± 0.7 points; 98.4% of patients were classified as high risk for VTE. Symptomatic VTE occurred in eight patients, and the overall incidence was 0.4%. The mean Caprini score for VTE patients was 8.8 ± 1.9 points. In the group with scores between 5 and 9 points, the incidence was 0.3–0.5%, while in patients with scores > 10 points, the incidence of VTE was found to be 1.12%.


The risk stratification system in the Caprini scoring model needs to be modified based on the actual incidence in the Korean population.



The authors thank Kyung-Hye Kwon for assistance with the data collection.




Mi-hyeong Kim, Kang-woong Jun, Jeong-kye Hwang, Sang-dong Kim, Jang-yong Kim, Sun-cheol Park, Yong-sung Won, Sang-seop Yun, In-sung Moon, and Ji-il Kim have no conflicts of interest to declare.


  1. 1.
    De Cicco M. The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol. 2004;50:187–96.CrossRefGoogle Scholar
  2. 2.
    Fuentes HE, Tafur AJ, Caprini JA. Cancer-associated thrombosis. Dis Mon. 2016;62:121–58.CrossRefGoogle Scholar
  3. 3.
    Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biologic and clinical aspects. J Thromb Haemost. 2013;11:223–33.CrossRefGoogle Scholar
  4. 4.
    Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70–8.CrossRefGoogle Scholar
  5. 5.
    Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251:344–50.CrossRefGoogle Scholar
  6. 6.
    Zhou HX, Peng LQ, Yan Y, et al. Validation of the caprini risk assessment model in Chinese hospitalized patients with venous thromboembolism. Thromb Res. 2012;130:735–40.CrossRefGoogle Scholar
  7. 7.
    Zhou H, Wang L, Wu X, et al. Validation of a venous thromboembolism risk assessment model in hospitalized chinese patients: a case-control study. J Atheroscler Thromb. 2014;21:261–72.CrossRefGoogle Scholar
  8. 8.
    Liew NC, Alemany GV, Angchaisuksiri P, et al. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Int Angiol. 2017;36:1–20.Google Scholar
  9. 9.
    Lee LH, Gallus A, Jindal R, et al. Incidence of venous thromboembolism in Asian populations: a systematic review. Thromb Haemost. 2017;117:2243–60.CrossRefGoogle Scholar
  10. 10.
    Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost. 2011;9:85–91.CrossRefGoogle Scholar
  11. 11.
    Yhim HY, Jang MJ, Bang SM, et al. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost. 2014;12:1035–43.CrossRefGoogle Scholar
  12. 12.
    Yu YB, Gau JP, Liu CY, et al. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost. 2012;108:225–35.CrossRefGoogle Scholar
  13. 13.
    Hong J, Lee JH, Yhim HY, et al. Incidence of venous thromboembolism in Korea from 2009 to 2013. PLoS ONE. 2018;13:e0191897.CrossRefGoogle Scholar
  14. 14.
    Law Y, Chan YC, Cheng SWK. Epidemiological updates of venous thromboembolism in a Chinese population. Asian J Surg. 2018;41:176–82.CrossRefGoogle Scholar
  15. 15.
    Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166:458–64.CrossRefGoogle Scholar
  16. 16.
    Hammond J, Kozma C, Hart JC, et al. Rates of venous thromboembolism among patients with major surgery for cancer. Ann Surg Oncol. 2011;18:3240–7.CrossRefGoogle Scholar
  17. 17.
    Heit JA. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis. 2006;21:23–9.CrossRefGoogle Scholar
  18. 18.
    Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001275.CrossRefGoogle Scholar
  19. 19.
    Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–9.CrossRefGoogle Scholar
  20. 20.
    White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res. 2009;123 Suppl 4:S11–7.CrossRefGoogle Scholar
  21. 21.
    Parikh KC, Oh D, Sittipunt C, et al. Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study. Thromb Res. 2012;129:e152–8.CrossRefGoogle Scholar
  22. 22.
    Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S–e77S.CrossRefGoogle Scholar
  23. 23.
    Klatsky AL, Amstrong MA, Poggi J. Risk of pulmonary embolism and or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334–7.CrossRefGoogle Scholar
  24. 24.
    Ridker PM, Miletich JP, Hnnekens CH, et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997;277:1305–7.Google Scholar
  25. 25.
    Lyman GH, Bohlke K, Khorana AA, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014. J Clin Oncol. 2015;33:654–6.CrossRefGoogle Scholar
  26. 26.
    Streiff MB, Holmstrom B, Ashrani A, et al. Cancer-associated venous thromboembolic disease, version 1.2015. J Natl Compr Canc Netw. 2015;13:1079–95.Google Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Mi-hyeong Kim
    • 1
  • Kang-woong Jun
    • 1
  • Jeong-kye Hwang
    • 1
  • Sang-dong Kim
    • 1
  • Jang-yong Kim
    • 1
  • Sun-cheol Park
    • 1
  • Yong-sung Won
    • 1
  • Sang-seop Yun
    • 1
  • In-sung Moon
    • 1
  • Ji-il Kim
    • 2
    Email author
  1. 1.Division of Vascular and Transplant Surgery, Department of Surgery, College of MedicineThe Catholic University of KoreaSeoulKorea
  2. 2.Division of Vascular and Transplant Surgery, Department of Surgery, Uijeongbu St. Mary’s Hospital, College of MedicineThe Catholic University of KoreaUijeongbu-siKorea

Personalised recommendations